4//SEC Filing
Afdhal Nezam H. 4
Accession 0001209191-19-005449
CIK 0001566373other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:35 PM ET
Size
5.5 KB
Accession
0001209191-19-005449
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-01-24+50,000→ 50,000 totalExercise: $10.35Exp: 2029-01-24→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 24, 2019, with 25% of the shares subject to the option vesting on January 24, 2020 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001664569
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 8:35 PM ET
- Size
- 5.5 KB